vs
Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.
TOMPKINS FINANCIAL CORP is the larger business by last-quarter revenue ($194.8M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs -82.0%, a 131.4% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs -22.7%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $-36.6M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs -11.5%).
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
PTCT vs TMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $164.7M | $194.8M |
| Net Profit | $-135.0M | $96.2M |
| Gross Margin | — | — |
| Operating Margin | -43.3% | 71.7% |
| Net Margin | -82.0% | 49.4% |
| Revenue YoY | -22.7% | 152.7% |
| Net Profit YoY | -104.8% | 388.9% |
| EPS (diluted) | $-1.63 | $6.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $164.7M | $194.8M | ||
| Q3 25 | $211.0M | $87.4M | ||
| Q2 25 | $178.9M | $82.6M | ||
| Q1 25 | $1.2B | $81.7M | ||
| Q4 24 | $213.2M | $77.1M | ||
| Q3 24 | $196.8M | $76.6M | ||
| Q2 24 | $186.7M | $72.7M | ||
| Q1 24 | $210.1M | $72.8M |
| Q4 25 | $-135.0M | $96.2M | ||
| Q3 25 | $15.9M | $23.7M | ||
| Q2 25 | $-64.8M | $21.5M | ||
| Q1 25 | $866.6M | $19.7M | ||
| Q4 24 | $-65.9M | $19.7M | ||
| Q3 24 | $-106.7M | $18.6M | ||
| Q2 24 | $-99.2M | $15.7M | ||
| Q1 24 | $-91.6M | $16.9M |
| Q4 25 | -43.3% | 71.7% | ||
| Q3 25 | 1.4% | 35.6% | ||
| Q2 25 | -19.5% | 34.2% | ||
| Q1 25 | 82.5% | 31.6% | ||
| Q4 24 | -76.2% | 33.4% | ||
| Q3 24 | -27.7% | 32.0% | ||
| Q2 24 | -21.5% | 28.3% | ||
| Q1 24 | -21.6% | 30.4% |
| Q4 25 | -82.0% | 49.4% | ||
| Q3 25 | 7.5% | 27.1% | ||
| Q2 25 | -36.3% | 26.0% | ||
| Q1 25 | 73.7% | 24.1% | ||
| Q4 24 | -30.9% | 25.5% | ||
| Q3 24 | -54.2% | 24.3% | ||
| Q2 24 | -53.1% | 21.6% | ||
| Q1 24 | -43.6% | 23.2% |
| Q4 25 | $-1.63 | $6.72 | ||
| Q3 25 | $0.20 | $1.65 | ||
| Q2 25 | $-0.83 | $1.50 | ||
| Q1 25 | $10.04 | $1.37 | ||
| Q4 24 | $-0.85 | $1.39 | ||
| Q3 24 | $-1.39 | $1.30 | ||
| Q2 24 | $-1.29 | $1.10 | ||
| Q1 24 | $-1.20 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | $132.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-205.3M | $938.4M |
| Total Assets | $2.9B | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | $132.8M | ||
| Q3 25 | $1.7B | $193.5M | ||
| Q2 25 | $2.0B | $212.6M | ||
| Q1 25 | $2.0B | $193.1M | ||
| Q4 24 | $1.1B | $134.4M | ||
| Q3 24 | $1.0B | $132.3M | ||
| Q2 24 | $1.1B | $70.9M | ||
| Q1 24 | $884.8M | $57.1M |
| Q4 25 | $-205.3M | $938.4M | ||
| Q3 25 | $-155.8M | $788.8M | ||
| Q2 25 | $-206.5M | $761.8M | ||
| Q1 25 | $-185.8M | $741.4M | ||
| Q4 24 | $-1.1B | $713.4M | ||
| Q3 24 | $-1.1B | $719.9M | ||
| Q2 24 | $-980.2M | $674.6M | ||
| Q1 24 | $-893.9M | $667.9M |
| Q4 25 | $2.9B | $8.7B | ||
| Q3 25 | $2.6B | $8.5B | ||
| Q2 25 | $2.6B | $8.4B | ||
| Q1 25 | $2.7B | $8.2B | ||
| Q4 24 | $1.7B | $8.1B | ||
| Q3 24 | $1.8B | $8.0B | ||
| Q2 24 | $1.9B | $7.9B | ||
| Q1 24 | $1.8B | $7.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.3M | $38.9M |
| Free Cash FlowOCF − Capex | $-36.6M | $31.9M |
| FCF MarginFCF / Revenue | -22.3% | 16.4% |
| Capex IntensityCapex / Revenue | 1.4% | 3.6% |
| Cash ConversionOCF / Net Profit | — | 0.40× |
| TTM Free Cash FlowTrailing 4 quarters | $702.3M | $105.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.3M | $38.9M | ||
| Q3 25 | $-66.3M | $34.9M | ||
| Q2 25 | $-58.3M | $18.9M | ||
| Q1 25 | $870.1M | $22.2M | ||
| Q4 24 | $-30.0M | $95.0M | ||
| Q3 24 | $-77.0M | $21.2M | ||
| Q2 24 | $-71.5M | $27.3M | ||
| Q1 24 | $70.8M | $23.2M |
| Q4 25 | $-36.6M | $31.9M | ||
| Q3 25 | $-69.7M | $33.9M | ||
| Q2 25 | $-59.6M | $18.3M | ||
| Q1 25 | $868.4M | $20.9M | ||
| Q4 24 | $-33.8M | $88.8M | ||
| Q3 24 | $-77.5M | $18.9M | ||
| Q2 24 | $-78.8M | $26.3M | ||
| Q1 24 | $61.2M | $21.9M |
| Q4 25 | -22.3% | 16.4% | ||
| Q3 25 | -33.1% | 38.8% | ||
| Q2 25 | -33.3% | 22.1% | ||
| Q1 25 | 73.8% | 25.5% | ||
| Q4 24 | -15.8% | 115.1% | ||
| Q3 24 | -39.4% | 24.7% | ||
| Q2 24 | -42.2% | 36.2% | ||
| Q1 24 | 29.1% | 30.0% |
| Q4 25 | 1.4% | 3.6% | ||
| Q3 25 | 1.6% | 1.1% | ||
| Q2 25 | 0.7% | 0.8% | ||
| Q1 25 | 0.1% | 1.7% | ||
| Q4 24 | 1.8% | 8.1% | ||
| Q3 24 | 0.3% | 2.9% | ||
| Q2 24 | 4.0% | 1.3% | ||
| Q1 24 | 4.6% | 1.9% |
| Q4 25 | — | 0.40× | ||
| Q3 25 | -4.17× | 1.47× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | 1.00× | 1.13× | ||
| Q4 24 | — | 4.82× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | — | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
